Sidley Austin has advised Osaka-based Takeda Pharmaceutical Co. Ltd. on its planned $800 million acquisition of URL Pharma, Inc., a maker of gout treatments based in Philadelphia. Ropes & Gray acted for URL.
April 12, 2012 at 12:00 AM
1 minute read
Sidley Austin has advised Japan’s Takeda Pharmaceutical Co. Ltd. on its planned acquisition of a rival U.S. drug maker.
Osaka-based Takeda, whose products range from diabetes medication to insomnia treatments, will pay $800 million for URL Pharma, Inc., a producer of gout medication based in Philadelphia, reports The Am Law Daily.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
